{'52WeekChange': 0.15801883,
 'SandP52WeekChange': None,
 'address1': '1 Cedar Brook Drive',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 14.56,
 'askSize': 4000,
 'averageDailyVolume10Day': 2980862,
 'averageVolume': 3080468,
 'averageVolume10days': 2980862,
 'beta': 1.347899,
 'beta3Year': None,
 'bid': 14.52,
 'bidSize': 3200,
 'bookValue': 1.564,
 'category': None,
 'circulatingSupply': None,
 'city': 'Cranbury',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 14.845,
 'dayLow': 14.34,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -12.609,
 'enterpriseToRevenue': 17.344,
 'enterpriseValue': 3619905024,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '609 662 2001',
 'fiftyDayAverage': 14.430285,
 'fiftyTwoWeekHigh': 16.13,
 'fiftyTwoWeekLow': 6.25,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 204567499,
 'forwardEps': -0.72,
 'forwardPE': -20.208332,
 'fromCurrency': None,
 'fullTimeEmployees': 584,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.01101,
 'heldPercentInstitutions': 1.0987201,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/amicusrx.com',
 'longBusinessSummary': 'Amicus Therapeutics, Inc., a biotechnology company, '
                        'engages in the discovery, development, and '
                        'commercialization of therapies to treat a range of '
                        'rare and orphan diseases. The company offers '
                        'Galafold, an orally administered small molecule '
                        'pharmacological chaperone for the treatment of Fabry '
                        'disease. It is also conducting Phase 3 (ATB200-03) '
                        'clinical study of AT-GAA for Pompe disease. The '
                        'company has collaboration and license agreements with '
                        "Nationwide Children's Hospital, University of "
                        'Pennsylvania, and GlaxoSmithKline. Amicus '
                        'Therapeutics, Inc. was founded in 2002 and is '
                        'headquartered in Cranbury, New Jersey.',
 'longName': 'Amicus Therapeutics, Inc.',
 'market': 'us_market',
 'marketCap': 3749011200,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_7009878',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -325036992,
 'nextFiscalYearEnd': 1640908800,
 'open': 14.51,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 13.9,
 'phone': '609 662 2000',
 'previousClose': 14.73,
 'priceHint': 2,
 'priceToBook': 9.303069,
 'priceToSalesTrailing12Months': 17.962261,
 'profitMargins': -1.55732,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 14.845,
 'regularMarketDayLow': 14.34,
 'regularMarketOpen': 14.51,
 'regularMarketPreviousClose': 14.73,
 'regularMarketPrice': 14.51,
 'regularMarketVolume': 2028653,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 257664000,
 'sharesPercentSharesOut': 0.1283,
 'sharesShort': 33069552,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 32281008,
 'shortName': 'Amicus Therapeutics, Inc.',
 'shortPercentOfFloat': 0.1291,
 'shortRatio': 8.77,
 'startDate': None,
 'state': 'NJ',
 'strikePrice': None,
 'symbol': 'FOLD',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.294,
 'twoHundredDayAverage': 11.431799,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '18ecfd93-9817-3a94-a13a-c6019ef27903',
 'volume': 2028653,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.amicusrx.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '08512'}